Advaxis, Inc. Advaxis Immunotherapy and the Tumor Microenvironment - WLOX.com - The News for South Mississippi

Advaxis, Inc. Advaxis Immunotherapy and the Tumor Microenvironment

Posted: Updated:

NEW YORK, NY / ACCESSWIRE / March 5, 2014 / Advaxis, Inc. (NASDAQ: ADXS) today published a new blog post on The Chairman’s Blog, written by the company’s CEO, Daniel J. O’Connor. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Mr. O’Connor writes about the unique properties of the Advaxis immunotherapy platform. He explains how the Company’s immunotherapies work and states, “We believe our immunotherapy goes a step beyond the others with an essential element that differentiates us from the competition.” Read the full blog post from Mr. Daniel J. O’Connor on TheChairmansBlog.com (http://www.thechairmansblog.com/advaxis/daniel-oconnor/advaxis-immunotherapy-tumor-microenvironment/).

 

About Advaxis, Inc.

Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis’s immunotherapies are based on a novel platform technology using live, attenuated bacteria to stimulate the immune system to selectively target cancer cells while reducing tumor defenses.

ADXS-HPV, Advaxis’s lead immunotherapy for the treatment of HPV-associated cancers, has demonstrated improved survival and objective tumor responses in a Phase 2 trial in 110 patients with recurrent cervical cancer. Advaxis is now planning the registrational program for ADXS-HPV. ADXS-HPV is also being evaluated in other HPV-associated cancers including a Phase 2 in advanced cervical cancer, a Phase 1/2 in head and neck cancer, and a Phase 1/2 in anal cancer. ADXS-HPV has orphan drug status for both anal and head and neck cancers. As part of its global commercialization strategy to enter into regional licensing deals with other market dominant biopharmaceutical companies in territories where there is a high prevalence of HPV-associated cancers, Advaxis has granted exclusive licenses for the development and commercialization of ADXS-HPV in Asia and India.

ADXS-cHER2 is an immunotherapy for the treatment of HER2 overexpressing cancers (such as breast, gastric, esophageal, and other cancers in humans and for osteosarcoma in canines). Advaxis’s lead animal-health immunotherapy, ADXS-cHER2, has demonstrated encouraging survival data in a Phase 1 trial in canine osteosarcoma. These data provide the rationale to advance this same immunotherapy into a Phase 1 clinical trial in women with HER2-positive breast cancer. The Company is preparing an IND submission for ADXS-cHER2 in breast cancer in 2014.

Advaxis has created more than 20 distinct immunotherapies based on its platform, either directly or through strategic collaborations with recognized cancer centers of excellence. We have clinical research collaborations with the University of Pennsylvania, Brown University, the Georgia Regents University Cancer Center, the Icahn School of Medicine at Mount Sinai, and others.

For more information, visit http://www.advaxis.com/.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privatively held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

ReleaseID: 412734

  • Most Popular StoriesMost Popular StoriesMore>>

  • Two injured Omega Protein plant workers speak out

    Two injured Omega Protein plant workers speak out

    Thursday, July 31 2014 6:54 AM EDT2014-07-31 10:54:16 GMT
    Two of the men injured in the Omega Protein explosion on Monday are speaking out about the deadly blast. In an exclusive interview with WLOX, the men describe what happened, and how they survived.More >>
    Two of the men injured in the Omega Protein explosion on Monday are speaking out about the deadly blast. In an exclusive interview with WLOX News, the men describe what happened that day, and how they survived.More >>
  • Prostitution sting nets 31 arrests

    Prostitution sting nets 31 arrests

    Tuesday, April 20 2010 11:21 PM EDT2010-04-21 03:21:00 GMT
    31 people are in trouble with the law after a three day prostitution sting in Richmond. Police told NBC12 they targeted specific areas where residents and business owners complained about the illegal activity.More >>
  • Fire destroys the Old Cuevas Bistro

    Fire destroys the Old Cuevas Bistro

    Thursday, July 31 2014 10:30 AM EDT2014-07-31 14:30:03 GMT
    "Destroyed," is how Harrison County Fire Marshal Pat Sullivan described the aftermath of the fire at the Old Cuevas Bistro on Menge Avenue.
    More >>
    The owner of the Old Cuevas Bistro near Pass Christian says she does have insurance, and she hopes to rebuild. Rebuilding became necessary after a late night fire ripped through her restaurant. "Destroyed," is how Harrison County Fire Marshal Pat Sullivan described the aftermath of the fire at the Old Cuevas Bistro on Menge Avenue.More >>
Powered by WorldNow

208 DeBuys Road
Biloxi, MS 39531
(228) 896-1313

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and WLOX. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.